A yeast two-hybrid screen performed to identify binding partners of the CaR (calcium-sensing receptor) intracellular tail identified the adaptor protein 14-3-3θ as a novel binding partner that bound to the proximal membrane region important for CaR expression and signalling. The 14-3-3θ protein directly interacted with the CaR tail in pull-down studies and FLAG-tagged CaR co-immunoprecipitated with EGFP (enhanced green fluorescent protein)-tagged 14-3-3θ when co-expressed in HEK (human embryonic kidney)-293 or COS-1 cells. The interaction between the CaR and 14-3-3θ did not require a putative binding site in the membrane-proximal region of the CaR tail and was independent of PKC (protein kinase C) phosphorylation. Confocal microscopy demonstrated co-localization of the CaR and EGFP–14-3-3θ in the ER (endoplasmic reticulum) of HEK-293 cells that stably expressed the CaR (HEK-293/CaR cells), but 14-3-3θ overexpression had no effect on membrane expression of the CaR. Overexpression of 14-3-3θ in HEK-293/CaR cells attenuated CaR-mediated Rho signalling, but had no effect on ERK (extracellular-signal-regulated kinase) 1/2 signalling. Another isoform identified from the library, 14-3-3ζ, exhibited similar behaviour to that of 14-3-3θ with respect to CaR tail binding, cellular co-localization and impact on receptor-mediated signalling. However, unlike 14-3-3θ, this isoform, when overexpressed, significantly reduced CaR plasma membrane expression. Results indicate that 14-3-3 proteins mediate CaR-dependent Rho signalling and may modulate the plasma membrane expression of the CaR.
Skip Nav Destination
Article navigation
Research Article|
January 16 2012
The adaptor protein 14-3-3 binds to the calcium-sensing receptor and attenuates receptor-mediated Rho kinase signalling
Ajanthy Arulpragasam;
Ajanthy Arulpragasam
*Western Australian Institute for Medical Research, QEII Medical Centre, Hospital Avenue, Nedlands, WA 6009, Australia
†University of Western Australia Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia
‡Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
Search for other works by this author on:
Aaron L. Magno;
Aaron L. Magno
*Western Australian Institute for Medical Research, QEII Medical Centre, Hospital Avenue, Nedlands, WA 6009, Australia
†University of Western Australia Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia
‡Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
Search for other works by this author on:
Evan Ingley;
Evan Ingley
*Western Australian Institute for Medical Research, QEII Medical Centre, Hospital Avenue, Nedlands, WA 6009, Australia
†University of Western Australia Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia
Search for other works by this author on:
Suzanne J. Brown;
Suzanne J. Brown
‡Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
Search for other works by this author on:
Arthur D. Conigrave;
Arthur D. Conigrave
§School of Molecular Bioscience, University of Sydney, Sydney, NSW 2000, Australia
Search for other works by this author on:
Thomas Ratajczak;
Thomas Ratajczak
*Western Australian Institute for Medical Research, QEII Medical Centre, Hospital Avenue, Nedlands, WA 6009, Australia
†University of Western Australia Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia
‡Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
Search for other works by this author on:
Bryan K. Ward
Bryan K. Ward
1
*Western Australian Institute for Medical Research, QEII Medical Centre, Hospital Avenue, Nedlands, WA 6009, Australia
†University of Western Australia Centre for Medical Research, University of Western Australia, Nedlands, WA 6009, Australia
‡Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009, Australia
1To whom correspondence should be addressed (email bryanw@cyllene.uwa.edu.au).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
July 18 2011
Revision Received:
October 03 2011
Accepted:
October 19 2011
Accepted Manuscript online:
October 19 2011
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2012 Biochemical Society
2012
Biochem J (2012) 441 (3): 995–1007.
Article history
Received:
July 18 2011
Revision Received:
October 03 2011
Accepted:
October 19 2011
Accepted Manuscript online:
October 19 2011
Citation
Ajanthy Arulpragasam, Aaron L. Magno, Evan Ingley, Suzanne J. Brown, Arthur D. Conigrave, Thomas Ratajczak, Bryan K. Ward; The adaptor protein 14-3-3 binds to the calcium-sensing receptor and attenuates receptor-mediated Rho kinase signalling. Biochem J 1 February 2012; 441 (3): 995–1007. doi: https://doi.org/10.1042/BJ20111277
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.

